MedElevator Войти в исследования
← Поиск публикаций

DOI 10.5152/tjg.2025.24726

Медицинская библиотека · The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2025

Gasdermin D: A New Inflammatory Biomarker in Assessing Clinical Disease Activity in Crohn's Disease.

Buldukoglu Osman Cagin, Ocal Serkan, Atar Galip Egemen, Kaya Besir, Isik Muhammet Devran, Aydin Tigli Gul, Akca Serdar, Harmandar Ferda Akbay, Cekin Yesim, Cekin Ayhan Hilmi

СтатьяПеревод пока не подготовлен

Аннотация

Background/Aims: Crohn's disease (CD) is an inflammatory, progressive disorder requiring monitoring of treatment response and disease course. Gasdermin D (GSDMD), a protein belonging to the gasdermin protein family, plays a role in inflammatory cell death, and activation of GSDMD has been shown to be a component of the pathogenesis of inflammatory bowel disease. Considering the role that GSDMD plays in inflammation, it was hypothesized that disease activity in CD may be correlated with serum GSDMD levels. The aim of this study was to assess the strength of GSDMD in predicting clinical disease activity in patients with CD in a prompt and easy manner. Materials and

Methods

This cross-sectional study was conducted over a span of 22 months from September 2022 to June 2024. A total of 61 patients with CD were included in the study. Demographic data, disease- and treatment-related data, and laboratory workups of the patients were recorded and analyzed.

Results

Gasdermin D levels were statistically significant in their correlation with the Harvey-Bradshaw Index (HBI) scores of the study population (P = .019). A threshold value of 5 ng/mL for GSDMD had a sensitivity of 84.6% and a specificity of 91.7% in differentiating patients with remission or mild disease from those with moderate or severe disease, according to HBI.

Conclusion

This pioneering study revealed that serum GSDMD can be used as a biomarker to assess clinical disease activity in patients with CD. Future studies incorporating colonoscopic evaluation into the equation will provide more insight into the use of this protein as a surrogate marker of disease progression in CD.

Для цитирования: Buldukoglu Osman Cagin, Ocal Serkan, Atar Galip Egemen, Kaya Besir, Isik Muhammet Devran, Aydin Tigli Gul, Akca Serdar, Harmandar Ferda Akbay, Cekin Yesim, Cekin Ayhan Hilmi. Gasdermin D: A New Inflammatory Biomarker in Assessing Clinical Disease Activity in Crohn's Disease.. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology. 2025. DOI: 10.5152/tjg.2025.24726.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.